Cardinal Health Company Profile (NYSE:CAH)

About Cardinal Health (NYSE:CAH)

Cardinal Health logoCardinal Health, Inc. is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear pharmacies and cyclotron facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and provides services to healthcare companies. The Medical segment distributes a range of medical, surgical and laboratory products, and provides services to hospitals, ambulatory surgery centers, clinical laboratories and other healthcare providers. This segment also manufactures, sources and develops its own Cardinal Health brand medical and surgical products. It provides post-acute care management and transition services, and software to hospitals.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drug Retailers - NEC
  • Sub-Industry: Health Care Distributors
  • Symbol: NYSE:CAH
  • CUSIP: 14149Y10
  • Web:
  • Market Cap: $24.42404 billion
  • Outstanding Shares: 315,882,000
Average Prices:
  • 50 Day Moving Avg: $76.85
  • 200 Day Moving Avg: $77.11
  • 52 Week Range: $62.70 - $85.52
  • Trailing P/E Ratio: 18.21
  • Foreward P/E Ratio: 14.64
  • P/E Growth: 2.89
Sales & Book Value:
  • Annual Revenue: $128.39 billion
  • Price / Sales: 0.19
  • Book Value: $21.03 per share
  • Price / Book: 3.63
  • Annual Dividend: $1.85
  • Dividend Yield: 2.4%
  • EBIDTA: $3.1 billion
  • Net Margins: 1.05%
  • Return on Equity: 25.78%
  • Return on Assets: 4.89%
  • Debt-to-Equity Ratio: 0.73%
  • Current Ratio: 1.13%
  • Quick Ratio: 0.54%
  • Average Volume: 2.04 million shs.
  • Beta: 0.81
  • Short Ratio: 3.22
Frequently Asked Questions for Cardinal Health (NYSE:CAH)

What is Cardinal Health's stock symbol?

Cardinal Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "CAH."

How often does Cardinal Health pay dividends? What is the dividend yield for Cardinal Health?

Cardinal Health announced a quarterly dividend on Wednesday, May 3rd. Stockholders of record on Monday, July 3rd will be paid a dividend of $0.4624 per share on Saturday, July 15th. This represents a $1.85 dividend on an annualized basis and a dividend yield of 2.42%. The ex-dividend date is Thursday, June 29th. This is a positive change from Cardinal Health's previous quarterly dividend of $0.45. View Cardinal Health's Dividend History.

How were Cardinal Health's earnings last quarter?

Cardinal Health, Inc. (NYSE:CAH) issued its quarterly earnings data on Monday, May, 1st. The company reported $1.53 EPS for the quarter, topping the Thomson Reuters' consensus estimate of $1.46 by $0.07. The firm had revenue of $31.82 billion for the quarter, compared to analysts' expectations of $32.30 billion. Cardinal Health had a return on equity of 25.78% and a net margin of 1.05%. The company's quarterly revenue was up 3.8% on a year-over-year basis. During the same period in the prior year, the firm posted $1.43 EPS. View Cardinal Health's Earnings History.

When will Cardinal Health make its next earnings announcement?

Cardinal Health is scheduled to release their next quarterly earnings announcement on Monday, July, 31st 2017. View Earnings Estimates for Cardinal Health.

Where is Cardinal Health's stock going? Where will Cardinal Health's stock price be in 2017?

17 analysts have issued 12 month price objectives for Cardinal Health's shares. Their predictions range from $72.00 to $93.00. On average, they anticipate Cardinal Health's share price to reach $83.46 in the next twelve months. View Analyst Ratings for Cardinal Health.

What are analysts saying about Cardinal Health stock?

Here are some recent quotes from research analysts about Cardinal Health stock:

  • 1. According to Zacks Investment Research, "Cardinal Health ended third-quarter fiscal 2017 on a solid note, courtesy of encouraging performance in the Medical segment. However, revenues missed the estimate mark in the quarter. Profits at the Pharmaceutical segment were hurt by generic pharmaceutical pricing and the loss of a major Pharmaceutical Distribution customer. Over the past one year, the company has underperformed the broader industry with respect to price. Increasing generic pricing pressure is a major headwind at the moment. Moreover, intensifying competition and customer concentration are other bottlenecks. Sluggish macroeconomic situations and a tough product pricing environment are also likely to dent growth. The company is banking on strategic buyouts, joint ventures and supply agreements to drive growth. Despite the strong prospects, integration risks are likely to mar the company's bottom line in the near term." (7/4/2017)
  • 2. Leerink Swann analysts commented, "We were disappointed by the pharmaceutical operating margin of 1.92% (-24 bps y/y) which was below our 2.02%E, though operating income itself was ahead of our estimate. The Medical division revenue was slightly ahead of our model, and operating income of $122M (margin of 3.80% vs. 4.49%E) was roughly in-line. Cordis is seasonal in nature and as a result earnings were good in Medical last quarter. F2017 Outlook Tough but Long-term +10-15% EPS Growth Guidance Good. Management provided F2017 guidance of $5.48-$5.73. The midpoint of guidance of $5.61 is below consensus of $5.69 and CAH indicated that F1Q:17 pharma operating income would decline in the ‘high teens to low twenty percent range,’ though be flat for F2017 relative to F2016. While this would normally be highly worrisome, management did a good job explaining that F1Q:16 EPS grew +38% y/y and the comp. is difficult due largely to generic pricing trends. In CAH’s prepared presentation, and on the call, management highlighted that they ‘aspire’ to grow adjusted EPS by +10-15% y/y over the longer term. Net customer activity and pricing is expected to have a ($0.55) headwind on F2017 results, tied mainly to Safeway, generic deflation, and less incremental earnings from new generic launches and Red Oak." (8/3/2016)

Are investors shorting Cardinal Health?

Cardinal Health saw a increase in short interest during the month of June. As of June 30th, there was short interest totalling 10,498,346 shares, an increase of 55.4% from the June 15th total of 6,756,952 shares. Based on an average daily trading volume, of 2,700,926 shares, the days-to-cover ratio is currently 3.9 days. Approximately 3.3% of the shares of the company are short sold.

Who are some of Cardinal Health's key competitors?

Who are Cardinal Health's key executives?

Cardinal Health's management team includes the folowing people:

  • George S. Barrett, Chairman of the Board, Chief Executive Officer
  • Michael C. Kaufmann, Chief Financial Officer
  • Donald M. Casey Jr., Chief Executive Officer - Medical Segment
  • Jon L. Giacomin, Chief Executive Officer - Pharmaceutical segment
  • Pamela O. Kimmet, Chief Human Resource Officer
  • Patricia B. Morrison, Executive Vice President - Customer Support Services and Chief Information Officer
  • Craig S. Morford, Chief Legal and Compliance Officer
  • Gregory B. Kenny, Lead Independent Director
  • David John Anderson, Independent Director
  • Colleen F. Arnold, Independent Director

Who owns Cardinal Health stock?

Cardinal Health's stock is owned by a variety of of retail and institutional investors. Top institutional investors include APG Asset Management N.V. (0.46%), Hexavest Inc. (0.31%), Bank of Montreal Can (0.22%), US Bancorp DE (0.13%), CWM LLC (0.11%) and National Pension Service (0.09%). Company insiders that own Cardinal Health stock include Carole S Watkins, Craig S Morford, Donald M Jr Casey, Falk T Stephen, George S Barrett, Jon L Giacomin, Patricia Morrison and Stuart G Laws. View Institutional Ownership Trends for Cardinal Health.

Who sold Cardinal Health stock? Who is selling Cardinal Health stock?

Cardinal Health's stock was sold by a variety of institutional investors in the last quarter, including US Bancorp DE, Reinhart Partners Inc., Hexavest Inc., Whittier Trust Co., Denali Advisors LLC, NN Investment Partners Holdings N.V., Aperio Group LLC and Huntington National Bank. Company insiders that have sold Cardinal Health stock in the last year include Craig S Morford, Donald M Jr Casey, George S Barrett, Jon L Giacomin, Patricia Morrison and Stuart G Laws. View Insider Buying and Selling for Cardinal Health.

Who bought Cardinal Health stock? Who is buying Cardinal Health stock?

Cardinal Health's stock was bought by a variety of institutional investors in the last quarter, including Bank of Montreal Can, Manning & Napier Advisors LLC, Mn Services Vermogensbeheer B.V., National Pension Service, APG Asset Management N.V., CrestPoint Capital Management LLC, Farmers & Merchants Investments Inc. and Sit Investment Associates Inc.. View Insider Buying and Selling for Cardinal Health.

How do I buy Cardinal Health stock?

Shares of Cardinal Health can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Cardinal Health's stock price today?

One share of Cardinal Health stock can currently be purchased for approximately $76.29.

MarketBeat Community Rating for Cardinal Health (NYSE CAH)
Community Ranking:  3.2 out of 5 (  )
Outperform Votes:  422 (Vote Outperform)
Underperform Votes:  243 (Vote Underperform)
Total Votes:  665
MarketBeat's community ratings are surveys of what our community members think about Cardinal Health and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Cardinal Health (NYSE:CAH) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 14 Hold Ratings, 3 Buy Ratings
Consensus Rating:Hold (Score: 2.18)
Consensus Price Target: $83.46 (9.40% upside)

Analysts' Ratings History for Cardinal Health (NYSE:CAH)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
7/13/2017Credit Suisse Group AGReiterated RatingOutperform$81.00 -> $87.00LowView Rating Details
7/4/2017Evercore ISIReiterated RatingOutperformN/AView Rating Details
5/17/2017Jefferies Group LLCInitiated CoverageHold -> Hold$77.00MediumView Rating Details
4/28/2017Tigress FinancialInitiated CoverageNeutral -> NeutralLowView Rating Details
4/25/2017Cowen and CompanyLower Price TargetMarket Perform$89.00 -> $82.00LowView Rating Details
4/22/2017Barclays PLCReiterated RatingOverweight$88.00 -> $82.00LowView Rating Details
4/21/2017Leerink SwannSet Price TargetHold$72.00LowView Rating Details
4/19/2017William BlairDowngradeOutperform -> Market PerformLowView Rating Details
4/4/2017Needham & Company LLCInitiated CoverageHoldLowView Rating Details
1/3/2017MizuhoDowngradeBuy -> Neutral$79.00N/AView Rating Details
10/28/2016Robert W. BairdDowngradeOutperform -> Neutral$92.00 -> $82.00N/AView Rating Details
10/10/2016Cleveland ResearchDowngradeBuy -> NeutralN/AView Rating Details
9/19/2016Bank of America CorporationReiterated RatingHold$90.00N/AView Rating Details
9/16/2016Goldman Sachs Group, Inc. (The)DowngradeBuy -> Neutral$90.00 -> $83.00N/AView Rating Details
9/12/2016Morgan StanleyReiterated RatingHold$91.00N/AView Rating Details
8/4/2016Deutsche Bank AGBoost Price TargetHold$83.00 -> $89.00N/AView Rating Details
8/3/2016Citigroup Inc.Boost Price TargetNeutral$87.00 -> $93.00N/AView Rating Details
6/20/2016FBR & CoReiterated RatingBuyN/AView Rating Details
6/13/2016Royal Bank Of CanadaReiterated RatingBuyN/AView Rating Details
6/1/2016Raymond James Financial, Inc.DowngradeOutperform -> Market PerformN/AView Rating Details
4/18/2016Avondale PartnersInitiated CoverageOutperform$111.00N/AView Rating Details
(Data available from 7/22/2015 forward)


Earnings History for Cardinal Health (NYSE:CAH)
Earnings by Quarter for Cardinal Health (NYSE:CAH)
Earnings History by Quarter for Cardinal Health (NYSE CAH)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/1/2017Q3 2017$1.46$1.53$32.30 billion$31.82 billionViewListenView Earnings Details
2/7/2017Q217$1.23$1.34$33.63 billion$33.10 billionViewListenView Earnings Details
10/31/2016Q117$1.21$1.24$31.12 billion$32.00 billionViewListenView Earnings Details
8/2/2016Q416$1.13$1.14$31.06 billion$31.40 billionViewN/AView Earnings Details
4/28/2016Q316$1.33$1.43$30.54 billion$30.70 billionViewListenView Earnings Details
2/1/2016Q216$1.26$1.30$29.23 billion$31.40 billionViewN/AView Earnings Details
11/2/2015Q116$1.10$1.38$27.19 billion$28.10 billionViewN/AView Earnings Details
7/30/2015Q415$0.99$1.00$26.05 billion$27.50 billionViewListenView Earnings Details
4/30/2015Q3$1.16$1.19$24.40 billion$25.38 billionViewN/AView Earnings Details
1/29/2015Q215$1.11$1.20$23.43 billion$25.50 billionViewN/AView Earnings Details
10/30/2014Q115$0.96$1.00$22.43 billion$24.07 billionViewN/AView Earnings Details
8/4/2014Q414$0.81$0.83$21.88 billion$2.90 billionViewN/AView Earnings Details
5/1/2014Q314$1.01$1.01$21.72 million$21.40 millionViewN/AView Earnings Details
1/31/2014Q214$0.84$0.79$20.74 billion$22.20 billionViewN/AView Earnings Details
10/31/2013Q114$0.86$1.10$22.73 billion$24.50 billionViewN/AView Earnings Details
8/1/2013Q4 2013$0.77$0.79$24.56 billion$25.40 billionViewN/AView Earnings Details
5/2/2013Q3 2013$0.95$1.20$24.72 billion$24.60 billionViewN/AView Earnings Details
2/5/2013Q2 2013$0.86$0.93$24.61 million$22.75 millionViewN/AView Earnings Details
10/30/2012Q113$0.79$0.81$26.33 million$25.90 millionViewN/AView Earnings Details
8/2/2012$0.73$0.73ViewN/AView Earnings Details
5/3/2012$0.88$0.94ViewN/AView Earnings Details
2/2/2012$0.77$0.81ViewN/AView Earnings Details
10/27/2011$0.72$0.73ViewN/AView Earnings Details
8/4/2011$0.58$0.59ViewN/AView Earnings Details
4/28/2011$0.69$0.75ViewN/AView Earnings Details
2/3/2011$0.61$0.69ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Cardinal Health (NYSE:CAH)
2017 EPS Consensus Estimate: $5.28
2018 EPS Consensus Estimate: $5.24
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20173$1.21$1.26$1.23
Q2 20173$1.20$1.33$1.26
Q3 20173$1.43$1.60$1.50
Q4 20174$1.24$1.41$1.29
Q1 20183$1.16$1.18$1.17
Q2 20183$1.22$1.42$1.33
Q3 20183$1.41$1.57$1.47
Q4 20183$1.25$1.30$1.28
(Data provided by Zacks Investment Research)


Current Dividend Information for Cardinal Health (NYSE:CAH)
Most Recent Dividend:7/15/2017
Annual Dividend:$1.85
Dividend Yield:2.42%
Dividend Growth:13.10% (3 Year Average)
Payout Ratio:44.05% (Trailing 12 Months of Earnings)
34.58% (Based on This Year's Estimates)
35.51% (Based on Next Year's Estimates)
Track Record:12 Years of Consecutive Dividend Growth
Dividend Payments by Quarter for Cardinal Health (NYSE:CAH)

Dividend History by Quarter for Cardinal Health (NYSE CAH)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading and Institutional Ownership History for Cardinal Health (NYSE:CAH)
Insider Ownership Percentage: 0.94%
Institutional Ownership Percentage: 87.52%
Insider Trades by Quarter for Cardinal Health (NYSE:CAH)
Institutional Ownership by Quarter for Cardinal Health (NYSE:CAH)
Insider Trades by Quarter for Cardinal Health (NYSE:CAH)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/12/2017Jon L GiacominCEO of Cardinal Health's pharmaceutical segmentSell23,270$72.87$1,695,684.90View SEC Filing  
2/10/2017George S BarrettChairmanSell217,994$77.23$16,835,676.62View SEC Filing  
11/10/2016George S BarrettChairmanSell217,995$71.29$15,540,863.55View SEC Filing  
8/18/2016Patricia MorrisonInsiderSell43,959$82.50$3,626,617.50View SEC Filing  
8/18/2016Stuart G LawsSVPSell9,703$82.45$800,012.35View SEC Filing  
8/16/2016Jon L GiacominCEOSell47,251$82.77$3,910,965.27View SEC Filing  
8/11/2016Craig S MorfordInsiderSell12,697$83.13$1,055,501.61View SEC Filing  
8/10/2016Donald M Jr. CaseyCEOSell59,180$83.59$4,946,856.20View SEC Filing  
8/10/2016George S BarrettChairmanSell250,000$83.63$20,907,500.00View SEC Filing  
8/9/2016George S BarrettCEOSell129,818$83.76$10,873,555.68View SEC Filing  
8/8/2016George S BarrettCEOSell20,428$83.75$1,710,845.00View SEC Filing  
5/20/2016Carole S WatkinsInsiderSell84,617$77.33$6,543,432.61View SEC Filing  
11/6/2015Falk T. StephenEVPSell30,085$87.66$2,637,251.10View SEC Filing  
8/20/2015George S. BarrettCEOSell300,000$83.08$24,924,000.00View SEC Filing  
5/12/2015Falk T StephenEVPSell39,428$86.12$3,395,539.36View SEC Filing  
5/11/2015George S BarrettCEOSell300,000$86.44$25,932,000.00View SEC Filing  
3/4/2015Colleen F ArnoldDirectorSell9,801$87.65$859,057.65View SEC Filing  
3/3/2015Richard C NotebaertDirectorSell9,801$88.20$864,448.20View SEC Filing  
2/20/2015Carole S WatkinsInsiderSell33,847$87.00$2,944,689.00View SEC Filing  
2/10/2015Carole S WatkinsInsiderSell50,770$85.00$4,315,450.00View SEC Filing  
2/10/2015George S BarrettCEOSell300,000$84.87$25,461,000.00View SEC Filing  
11/7/2014Mark R BlakeEVPSell24,668$79.50$1,961,106.00View SEC Filing  
9/5/2014Carole S WatkinsInsiderSell40,794$75.00$3,059,550.00View SEC Filing  
9/4/2014Michael C KaufmannCEOSell50,216$74.95$3,763,689.20View SEC Filing  
8/27/2014Jeffrey William HendersonCFOSell26,567$72.63$1,929,561.21View SEC Filing  
8/18/2014Jeffrey William HendersonCFOSell78,637$72.06$5,666,582.22View SEC Filing  
8/18/2014Mark R BlakeEVPSell4,782$72.15$345,021.30View SEC Filing  
8/18/2014Michael C KaufmannCEOSell6,833$72.06$492,385.98View SEC Filing  
8/8/2014Craig S MorfordInsiderSell43,359$70.03$3,036,430.77View SEC Filing  
8/8/2014Jeffrey William HendersonCFOSell118,093$69.72$8,233,443.96View SEC Filing  
7/24/2014Mark R BlakeEVPSell23,114$73.41$1,696,798.74View SEC Filing  
7/24/2014Stuart G LawsCAOSell21,266$72.50$1,541,785.00View SEC Filing  
7/14/2014Jeffrey William HendersonCFOSell23,632$70.65$1,669,600.80View SEC Filing  
5/19/2014Mark BlakeEVPSell4,703$66.50$312,749.50View SEC Filing  
5/13/2014Mark BlakeEVPSell2,822$66.50$187,663.00View SEC Filing  
5/7/2014Jeffrey William HendersonCFOSell27,031$63.83$1,725,388.73View SEC Filing  
2/11/2014Mark BlakeEVPSell2,330$68.53$159,674.90View SEC Filing  
2/11/2014Michael KaufmannCEOSell388,995$67.46$26,241,602.70View SEC Filing  
2/10/2014George BarrettCEOSell200,000$66.64$13,328,000.00View SEC Filing  
2/5/2014Gregory KennyDirectorSell18,175$65.39$1,188,463.25View SEC Filing  
2/4/2014Carole WatkinsInsiderSell46,666$65.71$3,066,422.86View SEC Filing  
2/4/2014Falk StephenEVPSell17,926$65.56$1,175,228.56View SEC Filing  
2/4/2014Richard NotebaertDirectorSell10,727$65.68$704,549.36View SEC Filing  
11/11/2013George BarrettCEOSell200,000$62.71$12,542,000.00View SEC Filing  
9/11/2013Mark R BlakeEVPSell14,584$51.53$751,513.52View SEC Filing  
8/19/2013Mark BlakeEVPSell4,925$51.27$252,504.75View SEC Filing  
8/16/2013Falk StephenEVPSell10,000$51.50$515,000.00View SEC Filing  
8/15/2013Craig MorfordInsiderSell20,000$51.33$1,026,600.00View SEC Filing  
8/13/2013George BarrettCEOSell75,000$52.09$3,906,750.00View SEC Filing  
8/13/2013Jeffrey William HendersonCFOSell54,590$51.99$2,838,134.10View SEC Filing  
8/8/2013Calvin DardenDirectorSell3,254$51.48$167,515.92View SEC Filing  
8/5/2013Mark BlakeEVPSell29,166$51.53$1,502,923.98View SEC Filing  
7/26/2013Jeffrey William HendersonCFOSell76,781$50.99$3,915,063.19View SEC Filing  
7/18/2013Jeffrey William HendersonCFOSell57,623$49.99$2,880,573.77View SEC Filing  
7/15/2013Jeffrey William HendersonCFOSell14,660$49.99$732,853.40View SEC Filing  
7/11/2013Jeffrey William HendersonCFOSell83,211$48.99$4,076,506.89View SEC Filing  
6/19/2013John F FinnDirectorSell11,070$48.51$537,005.70View SEC Filing  
5/28/2013Jean G SpauldingDirectorSell8,350$47.35$395,372.50View SEC Filing  
5/22/2013Richard C NotebaertDirectorSell3,197$48.10$153,775.70View SEC Filing  
5/20/2013Carole S WatkinsInsiderSell4,612$48.00$221,376.00View SEC Filing  
5/20/2013Jean G SpauldingDirectorSell1,666$47.90$79,801.40View SEC Filing  
11/1/2012Stuart G LawsCAOSell2,564$41.22$105,688.08View SEC Filing  
10/4/2012Jeffrey William HendersonCFOSell46,226$40.00$1,849,040.00View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for Cardinal Health (NYSE:CAH)
Latest Headlines for Cardinal Health (NYSE:CAH)
DateHeadline logoCardinal Health, Inc. (NYSE:CAH) Given Average Rating of "Hold" by Brokerages - July 21 at 8:26 PM logoCardinal Health to explore strategic alternatives, China a big growth driver - July 21 at 6:28 PM logoDecreasing the Dosage to Increase Positive Patient Outcomes - July 21 at 6:28 PM logo[$$] Cardinal Health Exploring Options for China Unit - July 21 at 6:28 PM logoCardinal puts China unit on block - Seeking Alpha - July 20 at 6:39 PM logoCardinal Health Selling China Business Worth Up to $1.5 Billion - July 20 at 6:39 PM logo Analysts Anticipate Cardinal Health, Inc. (NYSE:CAH) Will Post Quarterly Sales of $32.81 Billion - July 20 at 9:53 AM logoCardinal Health, Inc. (CAH) Expected to Announce Earnings of $1.24 Per Share - July 18 at 10:14 PM logoCardinal Health, Inc. (CAH) Short Interest Update - July 18 at 7:00 AM logoHead to Head Analysis: Cardinal Health (CAH) and MWI Veterinary Supply (MWIV) - July 17 at 11:29 AM logoCardinal Health, Inc. (NYSE:CAH) Rating Reiterated by Credit Suisse Group - July 13 at 8:13 AM logoCardinal Health to Webcast Discussion of Fourth-Quarter and Year-End Results for Fiscal Year 2017 on August 2 - July 6 at 6:07 PM logoZacks Investment Research Lowers Cardinal Health, Inc. (NYSE:CAH) to Sell - July 4 at 11:04 AM logoIHS Markit Score Update: Rise in demand for ETFs holding Cardinal Health Inc is a positive for its shares - July 3 at 4:56 PM logoIHS Markit Score Update: Drop in demand for ETFs holding Cardinal Health Inc is a negative sign for its shares - June 30 at 4:58 PM logoNashville company settles whistleblower suit for $2.7 million - June 30 at 4:58 PM logoWalgreens-Rite Aid Merger Collapses: Is McKesson Victor or Victim? - June 29 at 6:01 PM logoCardinal Health, Inc. (CAH) Given Consensus Rating of "Hold" by Brokerages - June 26 at 8:13 PM logoSee what the IHS Markit Score report has to say about Cardinal Health Inc. - June 26 at 4:47 PM logoCardinal Health, Inc. (CAH) Expected to Announce Quarterly Sales of $32.84 Billion - June 24 at 8:30 AM logoCardinal Health, Inc. (CAH) Expected to Post Earnings of $1.24 Per Share - June 22 at 6:52 PM logoHow To YieldBoost CAH To 6.3% Using Options - Nasdaq - June 21 at 5:13 PM logoETFs with exposure to Cardinal Health, Inc. : June 15, 2017 - June 15 at 4:17 PM logoCardinal Health, Inc. (CAH) Upgraded to Buy by Vetr Inc. - June 14 at 12:22 AM logoAs America’s Opioid Crisis Spirals, Giant Drug Distributor McKesson Is Feeling the Pain - June 13 at 12:51 PM logoValuEngine Lowers Cardinal Health, Inc. (CAH) to Hold - June 11 at 9:34 PM logoCardinal Health Inc (CAH) Upgraded to "Buy" by Vetr Inc. - June 11 at 11:28 AM logoCardinal Health (CAH) vs. AmerisourceBergen Corp. (ABC) Critical Analysis - June 8 at 7:56 AM logoJohn Rogers Buys Cardinal Health, Mattel, Nielsen - Nasdaq - June 7 at 9:29 PM logo25 Ohio companies make new Fortune 500 list, with Cardinal Health overtaking Kroger - Columbus Business First - June 7 at 9:29 PM logo25 Ohio companies make new Fortune 500 list, with Cardinal Health overtaking Kroger - June 7 at 12:55 PM logoCardinal Health, Inc. breached its 50 day moving average in a Bullish Manner : CAH-US : June 5, 2017 - June 5 at 12:23 PM logoReviewing Cardinal Health (CAH) and AmerisourceBergen Corp. (ABC) - June 4 at 4:50 PM logoVetr Inc. Downgrades Cardinal Health Inc (CAH) to Hold - June 2 at 12:16 AM logoResearch-Based Insights on Oncology Published by Cardinal Health Specialty Solutions - June 1 at 4:38 PM logoCardinal Health, Inc. -- Moody's assigns Baa2 to Cardinal Health's notes; stable outlook - June 1 at 4:38 PM logoCardinal Health Inc (CAH) Expected to Post Quarterly Sales of $32.84 Billion - May 31 at 1:08 PM logoCardinal Health Inc (CAH) Given Average Rating of "Hold" by Analysts - May 30 at 8:33 PM logoETFs with exposure to Cardinal Health, Inc. : May 30, 2017 - May 30 at 4:09 PM logoCardinal Health Inc (CAH) Short Interest Update - May 30 at 7:02 AM logo Brokerages Anticipate Cardinal Health Inc (CAH) Will Announce Earnings of $1.26 Per Share - May 29 at 2:20 PM logoElectrical Stimulation Therapy and E-Qure - A Potential 20x in 18 Months or Less - May 25 at 5:27 PM logoRebound Reality; Best Tech Story: Jim Cramer's Best Blog - May 20 at 11:14 AM logoServices Stocks Under Scanner -- Rite Aid, Cardinal Health, AmerisourceBergen, and McKesson - PR Newswire (press release) - May 19 at 9:04 PM logoCramer: The Rebound is Real. Now What? - May 19 at 4:02 PM logoETFs with exposure to Cardinal Health, Inc. : May 19, 2017 - May 19 at 4:02 PM logoDrug distributor McKesson's upbeat forecast sends shares soaring - May 19 at 8:55 AM logoCardinal Health, Inc. :CAH-US: Earnings Analysis: Q3, 2017 By the Numbers : May 18, 2017 - May 18 at 11:23 AM logoBrokers Issue Forecasts for Cardinal Health Inc's FY2017 Earnings (CAH) - May 18 at 10:58 AM logoA 'smart' parking lot with weather sensors and digital space finders is in the works for Cardinal Health in Dublin - May 17 at 9:16 PM



Cardinal Health (CAH) Chart for Saturday, July, 22, 2017

This page was last updated on 7/22/2017 by Staff